EXAS
Exact Sciences Corporation
64.72
USD
This page is just a preview of the data found in TrendSpider’s full version
Exact Sciences Corporation stock is up 8.3% since 30 days ago. The next earnings date is Feb 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60.87% of the previous 22 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 20 Nov 20:52 | 17 Jan, 2025 | 50.00 | 90 | ||
| 22 Nov 14:55 | 17 Jan, 2025 | 60.00 | 133 | ||
| 28 Nov 18:01 | 19 Apr, 2024 | 92.50 | 57 | ||
| 28 Nov 18:03 | 17 Jan, 2025 | 92.50 | 7 | ||
| 29 Nov 17:53 | 19 Jan, 2024 | 55.00 | 1578 | ||
| 30 Nov 17:18 | 19 Jan, 2024 | 65.00 | 376 | ||
| 01 Dec 14:45 | 17 Jan, 2025 | 60.00 | 125 | ||
| 01 Dec 16:09 | 19 Jan, 2024 | 60.00 | 941 | ||
| 04 Dec 14:47 | 19 Apr, 2024 | 70.00 | 198 | ||
| 06 Dec 20:34 | 17 Jan, 2025 | 37.50 | 25 |
Exact Sciences Corporation provides cancer screening and diagnostic test products. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers.
